Andrei Iagaru, MD, highlights his latest research investigating the potential of 68Ga-RM2 PET-MRI as a detection method for patients with biochemically recurrent prostate cancer.
Categories
Andrei Iagaru, MD, highlights his latest research investigating the potential of 68Ga-RM2 PET-MRI as a detection method for patients with biochemically recurrent prostate cancer.